PatentJun 10, 2026, 04:02 PM
Polyrizon Receives European Patent Publication Notice for Nasal Drug Delivery
AI Summary
Polyrizon Ltd. announced that the European Patent Office (EPO) has completed technical preparations for the publication of its European patent application, "Mucoadhesive Polymers for Nasal Drug Delivery," under publication number EP 4751737. This patent application covers the company's proprietary Trap & Target (T&T) mucoadhesive polymer technology, designed to improve nasal drug delivery by enhancing formulation retention and drug absorption. The publication marks a significant step in strengthening Polyrizon's intellectual property portfolio and supporting future pharmaceutical applications and collaborations in the European market.
Key Highlights
- European Patent Office (EPO) published Polyrizon's patent application EP 4751737.
- The patent application is titled "Mucoadhesive Polymers for Nasal Drug Delivery."
- It covers Polyrizon's proprietary Trap & Target (T&T) mucoadhesive polymer technology platform.
- The technology aims to enhance drug absorption and efficient delivery via the nasal route.
- This publication is a significant milestone for strengthening the company's intellectual property portfolio.
- If granted, the patent will provide IP protection across multiple European markets.
Price Impact
More from PLRZ